Gadolinium Deposition in the Brain: Current Updates
Open Access
- 1 January 2019
- journal article
- review article
- Published by The Korean Society of Radiology in Korean Journal of Radiology
- Vol. 20 (1), 134-147
- https://doi.org/10.3348/kjr.2018.0356
Abstract
Gadolinium-based contrast agents (GBCAs) are commonly used for enhancement in MR imaging and have long been considered safe when administered at recommended doses. However, since the report that nephrogenic systemic fibrosis is linked to the use of GBCAs in subjects with severe renal diseases, accumulating evidence has suggested that GBCAs are not cleared entirely from our bodies; some GBCAs are deposited in our tissues, including the brain. GBCA deposition in the brain is mostly linked to the specific chelate structure of the GBCA: linear GBCAs were responsible for brain deposition in almost all reported studies. This review aimed to summarize the current knowledge about GBCA brain deposition and discuss its clinical implications.Keywords
Funding Information
- Konkuk University
This publication has 105 references indexed in Scilit:
- Brain-wide pathway for waste clearance captured by contrast-enhanced MRIJCI Insight, 2013
- Role of thermodynamic and kinetic parameters in gadolinium chelate stabilityJournal of Magnetic Resonance Imaging, 2009
- Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 CasesRadiology, 2009
- Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°CInvestigative Radiology, 2008
- Extracellular gadolinium contrast agents: Differences in stabilityEuropean Journal of Radiology, 2008
- Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical reviewBioMetals, 2008
- New Insights into Nephrogenic Systemic FibrosisJournal of the American Society of Nephrology, 2007
- A Preliminary Study Revealing a New Association in Patients Undergoing Maintenance Hemodialysis: Manganism Symptoms and T1 Hyperintense Changes in the Basal GangliaAmerican Journal Of Neuroradiology, 2007
- Nephrogenic Systemic Fibrosis, Gadolinium, and Iron MobilizationNew England Journal of Medicine, 2007
- Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicitiesHuman & Experimental Toxicology, 2007